These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Oral administration of Cystine and Theanine ameliorates oxaliplatin-induced chronic peripheral neuropathy in rodents. Kawashiri T; Kobayashi D; Egashira N; Tsuchiya T; Shimazoe T Sci Rep; 2020 Jul; 10(1):12665. PubMed ID: 32728157 [TBL] [Abstract][Full Text] [Related]
6. Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity. Minami T; Takeda M; Sata M; Kato H; Yano K; Sakai T; Tsujita R; Kawasaki K; Ito A Eur J Pharmacol; 2020 Aug; 880():173196. PubMed ID: 32416186 [TBL] [Abstract][Full Text] [Related]
7. Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents. Ushio S; Egashira N; Sada H; Kawashiri T; Shirahama M; Masuguchi K; Oishi R Eur J Cancer; 2012 Jun; 48(9):1407-13. PubMed ID: 21907570 [TBL] [Abstract][Full Text] [Related]
12. New pharmacological effect of fulvestrant to prevent oxaliplatin-induced neurodegeneration and mechanical allodynia in rats. Yamamoto S; Yamashita T; Ito M; Caaveiro JMM; Egashira N; Tozaki-Saitoh H; Tsuda M Int J Cancer; 2019 Oct; 145(8):2107-2113. PubMed ID: 30515800 [TBL] [Abstract][Full Text] [Related]
14. Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice. Renn CL; Carozzi VA; Rhee P; Gallop D; Dorsey SG; Cavaletti G Mol Pain; 2011 Apr; 7():29. PubMed ID: 21521528 [TBL] [Abstract][Full Text] [Related]
15. Ameliorative effects of aqueous extract of Forsythiae suspensa fruits on oxaliplatin-induced neurotoxicity in vitro and in vivo. Yi JM; Shin S; Kim NS; Bang OS BMC Complement Altern Med; 2019 Nov; 19(1):339. PubMed ID: 31783843 [TBL] [Abstract][Full Text] [Related]
16. Behavioral and pharmacological characteristics of bortezomib-induced peripheral neuropathy in rats. Yamamoto S; Kawashiri T; Higuchi H; Tsutsumi K; Ushio S; Kaname T; Shirahama M; Egashira N J Pharmacol Sci; 2015 Sep; 129(1):43-50. PubMed ID: 26362518 [TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. Joseph EK; Chen X; Bogen O; Levine JD J Pain; 2008 May; 9(5):463-72. PubMed ID: 18359667 [TBL] [Abstract][Full Text] [Related]
18. Omeprazole Suppresses Oxaliplatin-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database. Mine K; Kawashiri T; Inoue M; Kobayashi D; Mori K; Hiromoto S; Kudamatsu H; Uchida M; Egashira N; Koyanagi S; Ohdo S; Shimazoe T Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012136 [TBL] [Abstract][Full Text] [Related]
19. Prazosin as an Adjuvant to Increase Effectiveness of Duloxetine in a Rat Model of Oxaliplatin-Induced Peripheral Neuropathy. Wagner MA; Smith EML; Ayyash N; Holden JE Semin Oncol Nurs; 2024 Oct; 40(5):151686. PubMed ID: 38897856 [TBL] [Abstract][Full Text] [Related]
20. Renin-Angiotensin-Aldosterone System Inhibitors Prevent the Onset of Oxaliplatin-Induced Peripheral Neuropathy: A Retrospective Multicenter Study and in Vitro Evaluation. Uchida M; Ushio S; Niimura T; Takechi K; Kawazoe H; Hidaka N; Tanaka A; Araki H; Zamami Y; Ishizawa K; Kitamura Y; Sendou T; Kawasaki H; Namba H; Shibata K; Tanaka M; Takatori S Biol Pharm Bull; 2022 Feb; 45(2):226-234. PubMed ID: 34803077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]